This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Commissariat a L'energie Atomique Et Aux Energies Alternatives, Elicityl. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,383 
1 out of 8,827 
1 out of 4 
Years Active: 2015
Title: Olivier Ferraris: Innovator in Influenza Treatment
Introduction
Olivier Ferraris is a notable inventor based in Bron, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases caused by the influenza virus. With a total of 2 patents, his work focuses on innovative solutions that aim to improve public health.
Latest Patents
Ferraris' latest patents include groundbreaking research on polysaccharides. One patent details the use of sulphated arabinogalactans, apiogalacturonans, and sulphated heteroglycans as potential drugs for the preventive or curative treatment of influenza virus infections. This invention emphasizes the importance of pharmaceutical compositions that include these polysaccharides in combination with at least one pharmaceutically acceptable carrier. Another significant patent involves modified viral strains and methods for enhancing the production of vaccine seeds for the influenza virus. This includes a modified influenza A/PR/8/34 virus and reassortant strains that incorporate a modified PB1 gene, aimed at improving the production of essential vaccine glycoproteins such as hemagglutinin (HA) and neuraminidase (NA).
Career Highlights
Throughout his career, Olivier Ferraris has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Claude Bernard Lyon 1. His research has been pivotal in advancing the understanding and treatment of influenza, showcasing his dedication to scientific innovation.
Collaborations
Ferraris has collaborated with notable colleagues, including Vincent Moules and Manuel Rosa-Calatrava. These partnerships have contributed to the success of his research and the development of his patents.
Conclusion
Olivier Ferraris stands out as an influential inventor in the realm of influenza treatment. His innovative patents and collaborations reflect his commitment to enhancing healthcare solutions. His work continues to pave the way for advancements in pharmaceutical research and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile